This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Care after abortion

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Rhesus prophylaxis

All non-sensitised RhD negative women should receive anti-D IgG within 72 hours following abortion, whether by surgical or medical methods:

  • should be injected into the deltoid muscle
  • recommended dose is 250 iu before 20 weeks and 500 iu thereafter
  • a 500 iu dose gives protection for fetomaternal haemorrhage of up to 4 mL
  • for abortions after 20 weeks of gestation, the size of fetomaternal haemorrhage should be assessed using either the traditional Kleihauer acid elution test or the more accurate flow cytometry
    • if test indicates a fetomaternal haemorrhage of greater than 4 mL, an additional 125 iu/mL of anti-D IgG should be administered

Information and follow-up

  • Following abortion, women must be provided with information (verbal and written) about symptoms which would necessitate an urgent medical consultation or symptoms suggestive of continuing pregnancy.
  • Women in whom successful abortion has not been confirmed at the time of the procedure should be offered follow-up to exclude continuing pregnancy.
  • Referral should be available for any woman who may require additional emotional support or whose mental health is perceived to be at risk.

Contraception

  • Before discharge, contraception methods should be discussed and initiated immediately, and contraceptive supplies should be offered.
  • Intrauterine contraceptives can be inserted immediately following medical and surgical abortion at all gestations as long as it is reasonably certain that the woman is not still pregnant.
  • Women who choose not to start a contraceptive method immediately should be informed about local contraceptive providers in addition to their GP.

Reference:

  1. Royal college of obstetricians and gynaecologists (RCOG) 2011. The care of women requesting induced abortion. Evidence based clinical guideline number 7.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.